pharma_company
stringclasses 562
values | brand_name_en
stringlengths 19
232
| generic_name_en
stringlengths 21
250
| substance_name_en
stringclasses 983
values | atc_code_raw
stringclasses 778
values | anatomical_desc
stringclasses 14
values | therapeutic_desc
stringclasses 82
values | pharmacological_desc
stringclasses 181
values | subpharmacological_desc
stringclasses 365
values | chemical_desc
stringclasses 636
values |
---|---|---|---|---|---|---|---|---|---|
Jalinous Pharmaceutical Co.
|
QUETIAPINE TABLET ORAL 25 mg
|
QUETIAPINE FUMARATE TABLET ORAL 25 mg
|
QUETIAPINE FUMARATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Rayhaneh Pharmaceutical Co.
|
REYPENTIN CAPSULE ORAL 100 mg
|
GABAPENTIN CAPSULE ORAL 100 mg
|
GABAPENTIN
|
N03AX12
|
NERVOUS SYSTEM
|
ANTIEPILEPTICS
|
ANTIEPILEPTICS
|
Other antiepileptics
|
gabapentin
|
Caspian Tamin Co.
|
NALOXONE INJECTION PARENTERAL 0.4 mg/1mL mL
|
NALOXONE HYDROCHLORIDE INJECTION PARENTERAL 0.4 mg/1mL
|
NALOXONE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Razak Labratories
|
ACETAMINOPHEN SOLUTION ORAL 120 mg/5mL 60 mL
|
ACETAMINOPHEN SOLUTION ORAL 120 mg/5mL 60 mL
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Pars Darou
|
BETAMETHASONE OINTMENT TOPICAL 0.1 % 15 g
|
BETAMETHASONE (AS VALERATE) OINTMENT TOPICAL 0.1 % 15 g
|
BETAMETHASONE (AS VALERATE)
|
D07AC01
|
DERMATOLOGICALS
|
CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
|
CORTICOSTEROIDS, PLAIN
|
Corticosteroids, potent (group III)
|
betamethasone
|
Aburaihan Pharmaceutical Co
|
CARDIOSAN TABLET ORAL 25 mg
|
LOSARTAN POTASSIUM TABLET ORAL 25 mg
|
LOSARTAN POTASSIUM
|
C09CA01
|
CARDIOVASCULAR SYSTEM
|
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
|
ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
|
Angiotensin II receptor blockers (ARBs), plain
|
losartan
|
Exir Pharmaceutical Company
|
BISOPEX TABLET ORAL 2.5 mg
|
BISOPROLOL FUMARATE TABLET ORAL 2.5 mg
|
BISOPROLOL FUMARATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Chema-elektromet. Spoldzielnia Pracy
|
NITROCARD OINTMENT TOPICAL 2 % 30 g
|
NITROGLYCERIN OINTMENT TOPICAL 2 % 30 g
|
NITROGLYCERIN
|
C01DA02
|
CARDIOVASCULAR SYSTEM
|
CARDIAC THERAPY
|
VASODILATORS USED IN CARDIAC DISEASES
|
Organic nitrates
|
glyceryl trinitrate
|
Samen Pharmaceutical Co
|
MAGNESIUM SULFATE INJECTION PARENTERAL 20 % 50 mL
|
MAGNESIUM SULFATE INJECTION PARENTERAL 20 % 50 mL
|
MAGNESIUM SULFATE
|
A12CC02
|
ALIMENTARY TRACT AND METABOLISM
|
MINERAL SUPPLEMENTS
|
OTHER MINERAL SUPPLEMENTS
|
Magnesium
|
magnesium sulfate
|
Amin Pharmaceutical Co.
|
TRIHEXYPHENIDYL TABLET ORAL 2 mg
|
TRIHEXYPHENIDYL HYDROCHLORIDE TABLET ORAL 2 mg
|
TRIHEXYPHENIDYL HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Tehran Chemie Pharmaceutical Co.
|
DEMITRON SOLUTION ORAL 4 mg/5mL 60 mL
|
ONDANSETRON SOLUTION ORAL 4 mg/5mL 60 mL
|
ONDANSETRON
|
A04AA01
|
ALIMENTARY TRACT AND METABOLISM
|
ANTIEMETICS AND ANTINAUSEANTS
|
ANTIEMETICS AND ANTINAUSEANTS
|
Serotonin (5HT3) antagonists
|
ondansetron
|
Pursina Pharmaceutical Co.
|
RISPERIDONE TABLET ORAL 2 mg
|
RISPERIDONE TABLET ORAL 2 mg
|
RISPERIDONE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
BETAMETHASONE OINTMENT TOPICAL 0.1 % 15 g
|
BETAMETHASONE (AS VALERATE) OINTMENT TOPICAL 0.1 % 15 g
|
BETAMETHASONE (AS VALERATE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
NO.115 , Jalal St ., Esteqlal Town ,Tehran
|
ACETAMINOPHEN/CAFFEINE/CODEINE TABLET ORAL 300 mg/15 mg/15 mg
|
ACETAMINOPHEN / CAFFEINE / CODEINE PHOSPHATE TABLET ORAL 300 mg/15 mg/15 mg
|
ACETAMINOPHEN / CAFFEINE / CODEINE PHOSPHATE
|
N02BE51
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol, combinations excl. psycholeptics
|
Jaber Ebne Hayyan
|
HYDROCORTISONE INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg mg
|
HYDROCORTISONE (AS SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg
|
HYDROCORTISONE (AS SODIUM SUCCINATE)
|
H02AB09
|
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
CORTICOSTEROIDS FOR SYSTEMIC USE
|
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
|
Glucocorticoids
|
hydrocortisone
|
Amin Pharmaceutical Co.
|
IMIPRAMINE TABLET ORAL 25 mg
|
IMIPRAMINE HYDROCHLORIDE TABLET ORAL 25 mg
|
IMIPRAMINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
INDOMETHACIN SUPPOSITORY RECTAL 100 mg
|
INDOMETHACIN SUPPOSITORY RECTAL 100 mg
|
INDOMETHACIN
|
M01AB01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
indometacin
|
Jalinous Pharmaceutical Co.
|
METRONIDAZOLE TABLET ORAL 500 mg
|
METRONIDAZOLE TABLET ORAL 500 mg
|
METRONIDAZOLE
|
P01AB01
|
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
ANTIPROTOZOALS
|
AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
|
Nitroimidazole derivatives
|
metronidazole
|
Raha Pharmaceutical Isfahan Company
|
RAQUIT TABLET ORAL 100 mg
|
QUETIAPINE FUMARATE TABLET ORAL 100 mg
|
QUETIAPINE FUMARATE
|
N05AH04
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Diazepines, oxazepines, thiazepines and oxepines
|
quetiapine
|
Rayhaneh Pharmaceutical Co.
|
A.S.A TABLET, DELAYED RELEASE ORAL 80 mg
|
ASA (ACETYLSALICYLIC ACID) TABLET, DELAYED RELEASE ORAL 80 mg
|
ASA (ACETYLSALICYLIC ACID)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Nik Saman Darou
|
HYDROXYZINE-EMAD SYRUP ORAL 10 mg/5mL 120 mL
|
HYDROXYZINE HYDROCHLORIDE SYRUP ORAL 10 mg/5mL 120 mL
|
HYDROXYZINE HYDROCHLORIDE
|
N05BB01
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANXIOLYTICS
|
Diphenylmethane derivatives
|
hydroxyzine
|
Daana Pharma
|
PROXAGEL CAPSULE, LIQUID FILLED ORAL 200 mg
|
NAPROXEN CAPSULE, LIQUID FILLED ORAL 200 mg
|
NAPROXEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
MELOXICAM-SHAFA TABLET ORAL 15 mg
|
MELOXICAM TABLET ORAL 15 mg
|
MELOXICAM
|
M01AC06
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Oxicams
|
meloxicam
|
Caspian Tamin Co.
|
ATROPINE SULFATE INJECTION PARENTERAL 0.5 mg/1mL mL
|
ATROPINE SULFATE INJECTION PARENTERAL 0.5 mg/1mL
|
ATROPINE SULFATE
|
A03BA01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
BELLADONNA AND DERIVATIVES, PLAIN
|
Belladonna alkaloids, tertiary amines
|
atropine
|
Ipsen
|
DIPHERELINE INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE PARENTERAL 11.25 mg mg
|
TRIPTORELIN (AS PAMOATE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE PARENTERAL 11.25 mg
|
TRIPTORELIN (AS PAMOATE)
|
L02AE04
|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
ENDOCRINE THERAPY
|
HORMONES AND RELATED AGENTS
|
Gonadotropin releasing hormone analogues
|
triptorelin
|
Tehran Chemie Pharmaceutical Co.
|
DEMETIC INJECTION PARENTERAL 5 mg/1mL 2 mL
|
METOCLOPRAMIDE INJECTION PARENTERAL 5 mg/1mL 2 mL
|
METOCLOPRAMIDE
|
A03FA01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
PROPULSIVES
|
Propulsives
|
metoclopramide
|
Sina Darou Laboratories
|
VENTALEX SPRAY, METERED RESPIRATORY 100 ug/1{dose} 200 {Puff}
|
SALBUTAMOL (AS SULFATE) SPRAY, METERED RESPIRATORY 100 ug/1{dose} 200 {dose}
|
SALBUTAMOL (AS SULFATE)
|
R03AC02
|
RESPIRATORY SYSTEM
|
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
ADRENERGICS, INHALANTS
|
Selective beta-2-adrenoreceptor agonists
|
salbutamol
|
Raha Pharmaceutical Isfahan Company
|
RAHAKIN TABLET, EXTENDED RELEASE ORAL 333 mg/145 mg
|
VALPROATE SODIUM TABLET, EXTENDED RELEASE ORAL 333 mg/145 mg
|
VALPROATE SODIUM
|
N03AG01
|
NERVOUS SYSTEM
|
ANTIEPILEPTICS
|
ANTIEPILEPTICS
|
Fatty acid derivatives
|
valproic acid
|
Exir Pharmaceutical Company
|
CLOVENT INJECTION, POWDER, FOR SOLUTION PARENTERAL 1000000 [iU] [iU]
|
COLISTIMETHATE SODIUM INJECTION, POWDER, FOR SOLUTION PARENTERAL 1000000 [iU]
|
COLISTIMETHATE SODIUM
|
J01XB01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
OTHER ANTIBACTERIALS
|
Polymyxins
|
colistin
|
Teb-mofid-nikan
|
SUMATRIPTAN TABLET ORAL 50 mg
|
SUMATRIPTAN (AS SUCCINATE) TABLET ORAL 50 mg
|
SUMATRIPTAN (AS SUCCINATE)
|
N02CC01
|
NERVOUS SYSTEM
|
ANALGESICS
|
ANTIMIGRAINE PREPARATIONS
|
Selective serotonin (5HT1) agonists
|
sumatriptan
|
Csl Behring Gmbh
|
FIBROGAMMIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 250 [iU] [iU]
|
FACTOR XIII INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 250 [iU]
|
FACTOR XIII
|
B02BD07
|
BLOOD AND BLOOD FORMING ORGANS
|
ANTIHEMORRHAGICS
|
VITAMIN K AND OTHER HEMOSTATICS
|
Blood coagulation factors
|
coagulation factor XIII
|
Amin Pharmaceutical Co.
|
CELEBRIN CAPSULE ORAL 200 mg
|
CELECOXIB CAPSULE ORAL 200 mg
|
CELECOXIB
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Dorsa darou
|
DOROFEN CAPSULE ORAL 325 mg/40 mg/200 mg
|
ACETAMINOPHEN / CAFFEINE / IBUPROFEN CAPSULE ORAL 325 mg/40 mg/200 mg
|
ACETAMINOPHEN / CAFFEINE / IBUPROFEN
|
N02BE71
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol, combinations with psycholeptics
|
Dorsa darou
|
ROUSANA TABLET ORAL 20 mg
|
ROSUVASTATIN (AS CALCIUM) TABLET ORAL 20 mg
|
ROSUVASTATIN (AS CALCIUM)
|
C10AA07
|
CARDIOVASCULAR SYSTEM
|
LIPID MODIFYING AGENTS
|
LIPID MODIFYING AGENTS, PLAIN
|
HMG CoA reductase inhibitors
|
rosuvastatin
|
Iran Daru
|
TRIAMTERENE-H TABLET ORAL 50 mg/25 mg
|
TRIAMTERENE / HYDROCHLOROTHIAZIDE TABLET ORAL 50 mg/25 mg
|
TRIAMTERENE / HYDROCHLOROTHIAZIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Alborzdarou
|
POLYPILL-V TABLET ORAL 81 mg/20 mg/12.5 mg/40 mg
|
ASA / ATORVASTATIN (AS CALCIUM) / HYDROCHLOROTHIAZIDE / VALSARTAN TABLET ORAL 81 mg/20 mg/12.5 mg/40 mg
|
ASA / ATORVASTATIN (AS CALCIUM) / HYDROCHLOROTHIAZIDE / VALSARTAN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
GELICAM GEL TOPICAL 0.5 g/100g 60 g
|
PIROXICAM GEL TOPICAL 0.5 g/100g 60 g
|
PIROXICAM
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
null |
DEXTROSE NACL 3.33% 0.3% (SHIRAZ SERUM) 1L INF P-BOTTLE INJECTION, SOLUTION INTRAVENOUS 3.33 %/0.3 % 1000
|
DEXTROSE / SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 3.33 %/0.3 % 1000 mL
|
DEXTROSE / SODIUM CHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sobhandarou
|
TRILOTOP NN OINTMENT TOPICAL 1 mg/2.5 mg/100000 [iU]/1g 15 g
|
TRIAMCINOLONE NN OINTMENT TOPICAL 1 mg/2.5 mg/100000 [iU]/1g 15 g
|
TRIAMCINOLONE NN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sina Darou Laboratories
|
DEXON INJECTION PARENTERAL 4 mg/1mL 2 mL
|
DEXAMETHASONE (AS DISODIUM PHOSPHATE) INJECTION PARENTERAL 4 mg/1mL 2 mL
|
DEXAMETHASONE (AS DISODIUM PHOSPHATE)
|
H02AB02
|
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
CORTICOSTEROIDS FOR SYSTEMIC USE
|
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
|
Glucocorticoids
|
dexamethasone
|
Toliddaru Pharma. Co.
|
PRANOL TABLET ORAL 10 mg
|
PROPRANOLOL HYDROCHLORIDE TABLET ORAL 10 mg
|
PROPRANOLOL HYDROCHLORIDE
|
C07AA05
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, non-selective
|
propranolol
|
Hakim Pharmaceutical Co.
|
DOMPERIDONE-HAKIM TABLET ORAL 10 mg
|
DOMPERIDONE TABLET ORAL 10 mg
|
DOMPERIDONE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Teb-mofid-nikan
|
CLINDAMYCIN CAPSULE ORAL 300 mg
|
CLINDAMYCIN (AS HYDROCHLORIDE) CAPSULE ORAL 300 mg
|
CLINDAMYCIN (AS HYDROCHLORIDE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Kishmedipharm
|
RUBOFEN GEL TOPICAL 5 % 50 g
|
IBUPROFEN GEL TOPICAL 5 % 50 g
|
IBUPROFEN
|
M02AA13
|
MUSCULO-SKELETAL SYSTEM
|
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
|
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
|
Antiinflammatory preparations, non-steroids for topical use
|
ibuprofen
|
Sajad Daru Shargh
|
ATENOLOL TABLET ORAL 50 mg
|
ATENOLOL TABLET ORAL 50 mg
|
ATENOLOL
|
C07AB03
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
atenolol
|
Sobhandarou
|
METHYL SALICYLATE OINTMENT TOPICAL 30 % 30 g
|
METHYL SALICYLATE OINTMENT TOPICAL 30 % 30 g
|
METHYL SALICYLATE
|
M02AC
|
MUSCULO-SKELETAL SYSTEM
|
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
|
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
|
Preparations with salicylic acid derivatives
| null |
Pharmachemie
|
DICLOFENAC SUPPOSITORY RECTAL 50 mg
|
DICLOFENAC SODIUM SUPPOSITORY RECTAL 50 mg
|
DICLOFENAC SODIUM
|
M01AB05
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
diclofenac
|
Mina Pharmaceutical&cosmetics Laboratory
|
DEXTROMETHORPHAN SYRUP ORAL 15 mg/5mL 60 mL
|
DEXTROMETHORPHAN HYDROBROMIDE SYRUP ORAL 15 mg/5mL 60 mL
|
DEXTROMETHORPHAN HYDROBROMIDE
|
R05DA09
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS
|
Opium alkaloids and derivatives
|
dextromethorphan
|
Teb-mofid-nikan
|
MODACINE TABLET ORAL 1 mg
|
COLCHICINE TABLET ORAL 1 mg
|
COLCHICINE
|
M04AC01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIGOUT PREPARATIONS
|
ANTIGOUT PREPARATIONS
|
Preparations with no effect on uric acid metabolism
|
colchicine
|
Iran Daru
|
FUROSEMIDE TABLET ORAL 40 mg
|
FUROSEMIDE TABLET ORAL 40 mg
|
FUROSEMIDE
|
C03CA01
|
CARDIOVASCULAR SYSTEM
|
DIURETICS
|
HIGH-CEILING DIURETICS
|
Sulfonamides, plain
|
furosemide
|
Avicenna Laboratories Inc.
|
DULOXETINE CAPSULE, DELAYED RELEASE ORAL 30 mg
|
DULOXETINE CAPSULE, DELAYED RELEASE ORAL 30 mg
|
DULOXETINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Zagros Darou Parsian
|
FAMOTIDINE TABLET ORAL 40 mg
|
FAMOTIDINE TABLET ORAL 40 mg
|
FAMOTIDINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Scott-Edil Pharmacia Ltd
|
CAFERMINE TABLET ORAL 1 mg/100 mg
|
ERGOTAMINE TARTRATE / CAFFEINE TABLET ORAL 1 mg/100 mg
|
ERGOTAMINE TARTRATE / CAFFEINE
|
N02CA72
|
NERVOUS SYSTEM
|
ANALGESICS
|
ANTIMIGRAINE PREPARATIONS
|
Ergot alkaloids
|
ergotamine, combinations with psycholeptics
|
Hakim Pharmaceutical Co.
|
ATENOKIM TABLET ORAL 50 mg
|
ATENOLOL TABLET ORAL 50 mg
|
ATENOLOL
|
C07AB03
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
atenolol
|
Farabi Pharmaceutical
|
AZITHROMYCIN CAPSULE ORAL 250 mg
|
AZITHROMYCIN CAPSULE ORAL 250 mg
|
AZITHROMYCIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
METOKIM TABLET ORAL 50 mg
|
METOPROLOL TARTRATE TABLET ORAL 50 mg
|
METOPROLOL TARTRATE
|
C07AB02
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
metoprolol
|
Behvazan Pharmaceutical
|
DICLOFENAC-BEHVAZAN SUPPOSITORY RECTAL 50 mg
|
DICLOFENAC SODIUM SUPPOSITORY RECTAL 50 mg
|
DICLOFENAC SODIUM
|
M01AB05
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
diclofenac
|
Iran Daru
|
HYDROCORTISONE OINTMENT TOPICAL 1 % 15 g
|
HYDROCORTISONE ACETATE OINTMENT TOPICAL 1 % 15 g
|
HYDROCORTISONE ACETATE
|
D07AA02
|
DERMATOLOGICALS
|
CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
|
CORTICOSTEROIDS, PLAIN
|
Corticosteroids, weak (group I)
|
hydrocortisone
|
Emad Darman Pars
|
SILVER SULFADIAZINE-EMAD CREAM TOPICAL 1 % 50 g
|
SILVER SULFADIAZINE CREAM TOPICAL 1 % 50 g
|
SILVER SULFADIAZINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Raha Pharmaceutical Isfahan Company
|
ANGIPOL TABLET, EXTENDED RELEASE ORAL 95 mg
|
METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE ORAL 95 mg
|
METOPROLOL SUCCINATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
NO.115 , Jalal St ., Esteqlal Town ,Tehran
|
FLAGIX TABLET ORAL 250 mg
|
METRONIDAZOLE TABLET ORAL 250 mg
|
METRONIDAZOLE
|
P01AB01
|
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
ANTIPROTOZOALS
|
AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
|
Nitroimidazole derivatives
|
metronidazole
|
Sina Darou Laboratories
|
NASOCALCIN SPRAY NASAL 100 [iU]/1 {dose} 16 mL
|
CALCITONIN, SALMON SPRAY NASAL 100 [iU]/1 {dose} 16 {Puff}
|
CALCITONIN, SALMON
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
SILDENAFIL TABLET ORAL 50 mg
|
SILDENAFIL (AS CITRATE) TABLET ORAL 50 mg
|
SILDENAFIL (AS CITRATE)
|
G04BE03
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
UROLOGICALS
|
UROLOGICALS
|
Drugs used in erectile dysfunction
|
sildenafil
|
Exir Pharmaceutical Company
|
LEVOFLOXACIN TABLET ORAL 750 mg
|
LEVOFLOXACIN TABLET ORAL 750 mg
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Avicenna Laboratories Inc.
|
FLUCONAZOLE TABLET ORAL 100 mg
|
FLUCONAZOLE TABLET ORAL 100 mg
|
FLUCONAZOLE
|
J02AC01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIMYCOTICS FOR SYSTEMIC USE
|
ANTIMYCOTICS FOR SYSTEMIC USE
|
Triazole derivatives
|
fluconazole
|
Amin Pharmaceutical Co.
|
ESOFLUX TABLET, DELAYED RELEASE ORAL 20 mg
|
ESOMEPRAZOLE TABLET, DELAYED RELEASE ORAL 20 mg
|
ESOMEPRAZOLE
|
A02BC05
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
esomeprazole
|
Sobhandarou
|
OXCARPIN TABLET ORAL 150 mg
|
OXCARBAZEPINE TABLET ORAL 150 mg
|
OXCARBAZEPINE
|
N03AF02
|
NERVOUS SYSTEM
|
ANTIEPILEPTICS
|
ANTIEPILEPTICS
|
Carboxamide derivatives
|
oxcarbazepine
|
Mina Pharmaceutical&cosmetics Laboratory
|
BROMHEXINE SOLUTION ORAL 4 mg/5mL 60 mL
|
BROMHEXINE HYDROCHLORIDE SOLUTION ORAL 4 mg/5mL 60 mL
|
BROMHEXINE HYDROCHLORIDE
|
R05CB02
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
|
Mucolytics
|
bromhexine
|
Hakim Pharmaceutical Co.
|
SIMVASTATIN-HAKIM TABLET ORAL 20 mg
|
SIMVASTATIN TABLET ORAL 20 mg
|
SIMVASTATIN
|
C10AA01
|
CARDIOVASCULAR SYSTEM
|
LIPID MODIFYING AGENTS
|
LIPID MODIFYING AGENTS, PLAIN
|
HMG CoA reductase inhibitors
|
simvastatin
|
Pfizer
|
VFEND INJECTION, POWDER, FOR SOLUTION PARENTERAL 200 mg mg
|
VORICONAZOLE INJECTION, POWDER, FOR SOLUTION PARENTERAL 200 mg
|
VORICONAZOLE
|
J02AC03
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIMYCOTICS FOR SYSTEMIC USE
|
ANTIMYCOTICS FOR SYSTEMIC USE
|
Triazole derivatives
|
voriconazole
|
Ati Pharmed Pharmaceutical Company
|
DESOLESTE TABLET ORAL 0.15 mg/30 ug
|
CONTRACEPTIVE DE TABLET ORAL 0.15 mg/30 ug
|
CONTRACEPTIVE DE
|
G03AA09
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
|
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
|
Progestogens and estrogens, fixed combinations
|
desogestrel and ethinylestradiol
|
Fareva Amboise
|
ARICEPT TABLET ORAL 5 mg
|
DONEPEZIL HYDROCHLORIDE TABLET ORAL 5 mg
|
DONEPEZIL HYDROCHLORIDE
|
N06DA02
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTI-DEMENTIA DRUGS
|
Anticholinesterases
|
donepezil
|
Sobhandarou
|
DILTIGEL GEL TOPICAL 2 % 30 g
|
DILTIAZEM HYDROCHLORIDE GEL TOPICAL 2 % 30 g
|
DILTIAZEM HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Caspian Tamin Co.
|
IPROID OINTMENT RECTAL 50 mg/2.75 mg/35 mg/180 mg/1g 15 g
|
ANTIHEMORRHOID OINTMENT RECTAL 50 mg/2.75 mg/35 mg/180 mg/1g 15 g
|
ANTIHEMORRHOID
|
C05AD01
|
CARDIOVASCULAR SYSTEM
|
VASOPROTECTIVES
|
AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
|
Local anesthetics
|
lidocaine
|
Farabi Pharmaceutical
|
PANTOPRAZOLE TABLET, DELAYED RELEASE ORAL 40 mg
|
PANTOPRAZOLE TABLET, DELAYED RELEASE ORAL 40 mg
|
PANTOPRAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sajad Daru Shargh
|
ATENOLOL TABLET ORAL 50 mg
|
ATENOLOL TABLET ORAL 50 mg
|
ATENOLOL
|
C07AB03
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
atenolol
|
Darou Pakhsh
|
DICLOFENAC SUPPOSITORY RECTAL 50 mg
|
DICLOFENAC SODIUM SUPPOSITORY RECTAL 50 mg
|
DICLOFENAC SODIUM
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Samisaz
|
MELOXIBE TABLET ORAL 7.5 mg
|
MELOXICAM TABLET ORAL 7.5 mg
|
MELOXICAM
|
M01AC06
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Oxicams
|
meloxicam
|
Hakim Pharmaceutical Co.
|
ACESTINE TABLET, EFFERVESCENT ORAL 600 mg
|
ACETYLCYSTEINE TABLET, EFFERVESCENT ORAL 600 mg
|
ACETYLCYSTEINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Hormone
|
PROURACIL TABLET ORAL 50 mg
|
PROPYLTHIOURACIL TABLET ORAL 50 mg
|
PROPYLTHIOURACIL
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
FENOPID CAPSULE ORAL 200 mg
|
FENOFIBRATE CAPSULE ORAL 200 mg
|
FENOFIBRATE
|
C10AB05
|
CARDIOVASCULAR SYSTEM
|
LIPID MODIFYING AGENTS
|
LIPID MODIFYING AGENTS, PLAIN
|
Fibrates
|
fenofibrate
|
Sajad Daru Shargh
|
FLUOXETINE CAPSULE ORAL 10 mg
|
FLUOXETINE (AS HYDROCHLORIDE) CAPSULE ORAL 10 mg
|
FLUOXETINE (AS HYDROCHLORIDE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pars Darou
|
EMPATUS TABLET ORAL 25 mg
|
EMPAGLIFLOZIN TABLET ORAL 25 mg
|
EMPAGLIFLOZIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Caspian Tamin Co.
|
ZEPADIC INJECTION PARENTERAL 5 mg/1mL 2 mL
|
DIAZEPAM INJECTION PARENTERAL 5 mg/1mL 2 mL
|
DIAZEPAM
|
N05BA01
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANXIOLYTICS
|
Benzodiazepine derivatives
|
diazepam
|
Sobhan Oncology
|
PEMEXED INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 mg mg
|
PEMETREXED INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 mg
|
PEMETREXED
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Dr. Abidi Pharmaceuticals
|
VALZOMIX TABLET ORAL 5 mg/160 mg
|
AMLODIPINE (AS BESILATE) / VALSARTAN TABLET ORAL 5 mg/160 mg
|
AMLODIPINE (AS BESILATE) / VALSARTAN
|
C09DB01
|
CARDIOVASCULAR SYSTEM
|
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
|
ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
|
Angiotensin II receptor blockers (ARBs) and calcium channel blockers
|
valsartan and amlodipine
|
Iran Hormone
|
NISOPRED TABLET ORAL 50 mg
|
PREDNISOLONE TABLET ORAL 50 mg
|
PREDNISOLONE
|
H02AB06
|
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
CORTICOSTEROIDS FOR SYSTEMIC USE
|
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
|
Glucocorticoids
|
prednisolone
|
Caspian Tamin Co.
|
VIBSIX INJECTION PARENTERAL 50 mg/1mL 2 mL
|
VITAMIN B6 INJECTION PARENTERAL 50 mg/1mL 2 mL
|
VITAMIN B6
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pursina Pharmaceutical Co.
|
ATENOLOL TABLET ORAL 50 mg
|
ATENOLOL TABLET ORAL 50 mg
|
ATENOLOL
|
C07AB03
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
atenolol
|
Raha Pharmaceutical Isfahan Company
|
COLOMEB TABLET ORAL 135 mg
|
MEBEVERINE HYDROCHLORIDE TABLET ORAL 135 mg
|
MEBEVERINE HYDROCHLORIDE
|
A03AA04
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
Synthetic anticholinergics, esters with tertiary amino group
|
mebeverine
|
Tehran Chemie Pharmaceutical Co.
|
NAPROXEN TABLET, DELAYED RELEASE ORAL 500 mg
|
NAPROXEN TABLET, DELAYED RELEASE ORAL 500 mg
|
NAPROXEN
|
M01AE02
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Propionic acid derivatives
|
naproxen
|
Pharmachemie
|
ASA TABLET, DELAYED RELEASE ORAL 80 mg
|
ASA (ACETYLSALICYLIC ACID) TABLET, DELAYED RELEASE ORAL 80 mg
|
ASA (ACETYLSALICYLIC ACID)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Razak Labratories
|
METHOCARBAMOL TABLET ORAL 500 mg
|
METHOCARBAMOL TABLET ORAL 500 mg
|
METHOCARBAMOL
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Mehr Darou
|
BUPRENORPHINE TABLET SUBLINGUAL 2 mg
|
BUPRENORPHINE (AS HYDROCHLORIDE) TABLET SUBLINGUAL 2 mg
|
BUPRENORPHINE (AS HYDROCHLORIDE)
|
N07BC01
|
NERVOUS SYSTEM
|
OTHER NERVOUS SYSTEM DRUGS
|
DRUGS USED IN ADDICTIVE DISORDERS
|
Drugs used in opioid dependence
|
buprenorphine
|
Zahravi Pharmaceutical
|
ADVIFEN CAPSULE, LIQUID FILLED ORAL 400 mg
|
IBUPROFEN CAPSULE, LIQUID FILLED ORAL 400 mg
|
IBUPROFEN
|
M01AE01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Propionic acid derivatives
|
ibuprofen
|
Farabi Pharmaceutical
|
FARAMOX BD POWDER, FOR SUSPENSION ORAL 400 mg/5 mL 70 mL
|
AMOXICILLIN POWDER, FOR SUSPENSION ORAL 400 mg/5 mL 70 mL
|
AMOXICILLIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Hormone
|
NISOPRED TABLET ORAL 50 mg
|
PREDNISOLONE TABLET ORAL 50 mg
|
PREDNISOLONE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Jalinous Pharmaceutical Co.
|
ESNEXOM TABLET, DELAYED RELEASE ORAL 40 mg
|
ESOMEPRAZOLE TABLET, DELAYED RELEASE ORAL 40 mg
|
ESOMEPRAZOLE
|
A02BC05
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
esomeprazole
|
Iran Daru
|
YOHIMBINE TABLET ORAL 2 mg
|
YOHIMBINE HYDROCHLORIDE TABLET ORAL 2 mg
|
YOHIMBINE HYDROCHLORIDE
|
G04BE04
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
UROLOGICALS
|
UROLOGICALS
|
Drugs used in erectile dysfunction
|
yohimbine
|
Teb-mofid-nikan
|
ACETAMINOPHEN TABLET ORAL 325 mg
|
ACETAMINOPHEN TABLET ORAL 325 mg
|
ACETAMINOPHEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.